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Abstract
BACKGROUND: Acute lower respiratory infections (ALRIs) are infectious diseases with high morbidity and mortality 
in children under five. There are several factors associated with ALRIs (bronchiolitis or pneumonia) that have been 
established. In recent years, Vitamin D level, Vitamin D receptor (VDR) gene polymorphism, and cathelicidin level are 
also associated with ALRIs. Until now, there was no VDR gene other than Fok1 identified at the exon 2-VDR gene. 
OBJECTIVE: The objective of this study was to establish whether Vitamin D deficiency, ff genotype-Fok1 VDR gene 
polymorphism, and low levels of cathelicidin are risk factors of ALRIs and to determine the pictures of exon 2-VDR 
genes polymorphisms in children under five.
METHODS: A matched case–control study was conducted in children under the age of five. There were 35 subjects 
who suffered from bronchiolitis or pneumonia and 35 healthy subjects as a control group. These groups were 
matched based on age and gender, and the children originated from the same neighborhood. Level of 25(OH) D, 
exon 2-VDR genes sequencing, and level of cathelicidin were investigated. Data were analyzed by the Chi-square 
test or Fisher exact test and logistic regression with a significant level of p < 0.05.
RESULTS: This study found that Vitamin D deficiency and low levels of cathelicidin were risk factors of ALRIs (odds 
ratio [OR] = 5.82 [95% confidence interval [CI] = 1.71–19.89], p = 0.005 and OR = 4.07 [95% CI = 1.10–15.12], 
p = 0.036, respectively), while ff genotype-Fok1 VDR gene polymorphism was not (OR = 1.12 [95% CI = 0.26–4.86], 
p = 1.000). Fok1 VDR gene polymorphism was the picture of exon 2-VDR gene polymorphisms.
CONCLUSION: It is concluded that Vitamin D deficiency and low levels of cathelicidin are risk factors, but ff 
genotype-Fok1 VDR gene polymorphism is not a risk factor of ALRIs. Fok1 VDR gene polymorphism is the picture 
of exon 2-VDR genes polymorphisms.
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Introduction
Bronchiolitis and pneumonia are two of the 
most common acute lower respiratory infections 
(ALRIs) in children under the age of five. The World 
Health Organization estimates about 150 million new 
cases of bronchiolitis every year, 95% of which occur in 
developing countries, and approximately 11–20 million 
(7–13%) require hospitalization [1]. Pneumonia is a high 
morbidity illness. The worldwide incidence of pneumonia 
in children under five in 2010 was 120 million, and 14 
million of which progressed to severe pneumonia [2]. 
The mortality rate of bronchiolitis ranged from 0.2% to 
7% [1], while the mortality rate of pneumonia is much 
higher. In 2011, the mortality rate of pneumonia was 
1.3 million [3] and 1.1 million in 2013 [4]. Ninety-nine 
percent of children under five who died due to pneumonia 
occur in developing countries [5]. In Indonesia, the 
mortality rate of pneumonia during 2012 was 13.2% [6].
There are several factors associated with ALRIs 
(bronchiolitis or pneumonia) [7], [8], [9], [10], [11], [12]. 
Some micronutrients, including Vitamin D, are also 
associated with ALRIs. Three studies report that Vitamin D 
is a protective factor of ALRIs [13], [14], [15], while other 
studies show no association between low Vitamin D 
intake and bronchiolitis [16], and no association between 
Vitamin D levels and ALRIs [17], [18].
In addition to low Vitamin D level [13], [14], [15], [19], 
other factors associated with ALRIs are Vitamin D 
receptor (VDR) gene polymorphisms [20], [21], [22], 
and cathelicidin (formed through the role of Vitamin D) 
level [23], [24], [25]. Different results are shown for VDR 
gene polymorphisms [26] and cathelicidin level [27].
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In addition to inconsistent results, all previous 
studies were conducted in subtropical countries on 
white or black ethnic subjects. We know that there is 
a difference in the time of sunlight exposure between 
the subtropical and tropical countries [28], and there 
is a difference in the skin’s ability to synthesize 
Vitamin D due to skin color [29], and there are 
ethnic variations on VDR gene polymorphisms [30]. 
Until recently, there has been no study in children 
simultaneously investigates the association between 
Vitamin D level, VDR gene polymorphism, and 
cathelicidin level with ALRIs, and there are no VDR 
genes, other than Fok1 that has been identified at 
exon 2-VDR gene. Therefore, this study was aimed to 
evaluate, whether Vitamin D deficiency, ff genotype-
Fok1 VDR gene polymorphism, and low levels of 
cathelicidin were risk factors of ALRIs, and to find out 
the presence of other gene polymorphisms in addition 
to Fok1 at exon 2-VDR gene.
Methods
This was a case–control study, performed at 
the Department of Child Health, Udayana University 
Medical School/Sanglah Hospital Denpasar. This 
study was conducted from April to October 2015 after 
approval from the Research Ethics Committee Udayana 
University Medical School/Sanglah Hospital Denpasar.
Samples for case and control groups were 
selected by consecutive sampling. We calculated 
sample size based on α = 0.05 and β = 10% (power 
90%) and found that the largest sample for three 
variables (Vitamin D deficiency, ff genotype-Fok1 VDR 
gene polymorphism, and low levels of cathelicidin) 
was 35 for each group. The parent or guardian of each 
subject gave informed consent. The inclusion criteria for 
the case group were children under five who suffered 
from hospitalized bronchiolitis or community-acquired 
pneumonia, while the inclusion criteria for the control 
group were healthy children under five who matched 
the case group in terms of age and sex and came from 
the same neighborhood. The exclusion criteria for the 
case group were subjects that suffered from congenital 
heart disease (CHD), immune deficiency, malnutrition, 
obesity, cerebral palsy, Vitamin A deficiency, and history 
of taking medications that contain Vitamin D since the 
acute respiratory infection (ARI) symptoms begin, or 
the parent refused to participate, while the exclusion 
criteria for the control group were the parent refused to 
participate.
Vitamin D and cathelicidin levels were 
investigated by enzyme-linked immunosorbent 
assay methods at Prodia Laboratory. The 
Vitamin D level was defined as deficient if the calcidiol 
level ≤20 ng/ml [31], [32], while the cathelicidin 
level was defined as low if the level of cathelicidin 
<50 ng/mL [33]. VDR gene polymorphisms were 
investigated by Sanger’s methods at Biochemistry 
and Genetic Science Laboratories, and the genotypes 
(ff, Ff, and FF) were investigated at Fok1 single 
nucleotide polymorphisms subject [21]. Bronchiolitis 
referred to the first episode of acute wheezing in 
children <2 years of age, starting as a viral upper 
respiratory infection (rhinorrhea, cough, or low-grade 
fever) [9], while pneumonia was established based on 
the presence of fever, cough, tachypnea, respiratory 
distress, crackles on chest auscultation, and infiltrates 
or consolidation on a chest radiograph [10], [12]. Subject 
characteristics and outcomes were initially analyzed 
by the Chi-square test or Fisher exact test and then 
continued by multivariable logistic regression analysis 
for variables that statistically significant at bivariate 
analysis. We also performed a subgroup analysis 
for the variable that statistically significant when be 
tested by bivariate analysis. p < 0.05 was considered 
statistically significant. All data were processed using 
computer software SPSS 23.0.
Results
During the study period, there were 63 
subjects that met the inclusion criteria for the case 
group and 44 subjects for the control group. For 
the case group, 28 subjects were excluded due to 
CHD (three subjects), obese (one subject), parents 
refused to participate (eight subjects), cerebral palsy 
(three subjects), immune deficiency (five subjects), 
malnutrition (six subjects), and two subjects had a 
history of taking vitamins since the ARI symptoms 
began. In the control group, nine subjects were 
excluded due to parents refused to participate in 
this study. Of the 35 case subjects, we obtained, 22 
subjects suffered from bronchiolitis, and 13 subjects 
suffered from pneumonia.
Overall, we found that 80% of subjects were 
2–11 months of age and 63% were male. There were no 
differences in characteristics between case and control 
groups except crowded residential environments 
(Table 1).
Table 1: Characteristics of the study subjects
Variables Case (n=35) Control (n=35) p
1. Age (2–11 months), n (%) 28 (80) 28 (80) 1.000a
2. Sex (male), n (%) 22 (63) 22 (63) 1.000a
3. Nutritional status, n (%):  
Underweight+overweight 10 (29) 8 (23) 0.584a
4. LBW history, n (%) 6 (17) 4 (11) 0.495a
5. Preterm delivery, n (%) 6 (17) 4 (11) 0.495a
6. Non-exclusive breastfeeding, n (%) 23 (66) 22 (63) 0.803a
7. Non-complete immunization status, n (%) 22 (63) 19 (54) 0.467a
8. Indoor air pollution, n (%) 9 (26) 6 (17) 0.382a
9. Crowded residential environment, n (%) 14 (40) 3 (9) 0.002a
10. Cigarette smoke exposure, n (%) 17 (49) 13 (37) 0.334a
11. Asthma, n (%) 1 (3) - 1.000b
12. Day care attendance, n (%) 1 (3) - 1.000b
The only significant p value in this characteristic is the crowded residential environment with p=0.002.  
aChi-square test, bFisher exact test.
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We found that 27 subjects in the case and eight 
subjects in control groups were Vitamin D deficiency. 
Bivariate analysis showed that Vitamin D deficiency 
was a risk factor of ALRIs. Subgroup analysis found that 
Vitamin D deficiency was a risk factor for bronchiolitis 
but questionable for pneumonia (Table 2).
Table 2: Risk of ALRIs, bronchiolitis, and pneumonia in 
Vitamin D deficiency subject
Case Control OR (95% CI) p
27 8 11.39 (3.73–34.76) <0.0001a
19 5 21.59 (4.46–103.90) <0.0001b
8 3 5.33 (0.97–29.39) 0.047c
The analysis showed that Vitamin D deficiency significantly was a risk factor for bronchiolitis but 
questionable for pneumonia. aALRIs, bBronchiolitis, cPneumonia. ALRIs: Acute lower respiratory infections, 
OR: Odds ratio, CI: Confidence interval.
After sequencing the PCR of the exon 2-VDR 
gene using primer reverse, no other genes obtained in 
addition to the Fok1 VDR gene. Nine (12.9%) subjects 
showed ff genotype, 25 (35.7%) subjects showed 
Ff genotype, and 36 (51.4%) subjects showed FF 
genotype. We found that both ff and Ff genotypes were 
not risk factors of ALRIs compared to the FF genotype 
(Table 3).
Table 3: Risk of ALRIs based on the genotype of Fok1 VDR 
gene polymorphisms
Fok1 VDR gene polymorphisms Case 
(n=35)
Control 
(n=35)
OR (95% CI) p
ff genotype 5 4 1.12 (0.26–4.86) 1.000b
Ff genotype 11 14 0.70 (0.25–1.96) 0.500a
FF genotype 19 17 1.00 (reference) -
ff and Ff genotypes were not risk factors of ALRIs compared to the FF genotype (p>0.05). aChi-square test, 
bFisher exact test. ALRIs: Acute lower respiratory infections, VDR: Vitamin D receptor.
We found that 25 subjects in the case and 
seven subjects in control groups were low levels of 
cathelicidin. Bivariate analysis showed that low levels 
of cathelicidin were a risk factor of ALRIs. Subgroup 
analysis found that low levels of cathelicidin were a 
risk factor for bronchiolitis and pneumonia (Table 4).
Table 4: Risk of ALRIs, bronchiolitis, and pneumonia in low-
level cathelicidin subjects
Case Control OR (95% CI) p
25 7 10.00 (3.31–30.23) <0.0001a
16 4 12.00 (2.86–50.31) <0.0001b
9 3 7.50 (1.31–43.03) 0.018c
Low levels of cathelicidin were a risk factor for bronchiolitis and pneumonia (p<0.0001). aALRIs, 
bBronchiolitis, cPneumonia. ALRIs: Acute lower respiratory infections, OR: Odds ratio, CI: Confidence 
interval.
Logistic regression analysis found that both Vitamin D 
deficiency and low levels of cathelicidin were risk factors 
of ALRIs (Table 5).
Table 5: Logistic regression multivariable analysis of ALRIs 
risk factors
Variables OR 95% CI p
Vitamin D deficiency 5.82 1.71–19.89 0.005
Low level of cathelicidin 4.07 1.10–15.12 0.036
Crowded residential environment 2.13 0.41–11.06 0.368
Both Vitamin D deficiency and low levels of cathelicidin were risk factors of ALRIs (p<0.05). ALRIs: Acute 
lower respiratory infections, OR: Odds ratio, CI: Confidence interval.
Discussion
In children under five, ALRIs are ARI with a 
fairly high incidence and high mortality rate (especially 
pneumonia with a mortality rate of 1.1 million in 
2013) [4]. There are several factors associated with 
ALRIs [7], [8], [9], [10], [11], [12]. We found that all of 
them were comparable in case and control groups 
except the crowded residential environment (Table 1). 
The crowded residential environment will facilitate germ 
transmission from one subject to another subject.
In addition to the role of calcium and bone 
metabolisms [34], in recent years, Vitamin D is 
also considered to play an important role in several 
diseases, including ALRIs. Calcidiol is the best 
indicator to determine total Vitamin D status in the 
body, although the biologically active form of Vitamin D 
is calcitriol [35], [36]. This study found that Vitamin D 
deficiency was a risk factor of ALRIs. Similar results are 
shown in other studies [13], [14], [15], [25], [37].
A different result was shown by 
Roth et al. [17] who found that the mean calcidiol levels 
were similar between case groups (ALRIs patients 
mainly bronchiolitis) and control (healthy children) 
groups (77 nmol/L vs. 77.2 nmol/L, p = 0.960). They 
did not analyze the role of the 1-OHase enzymes, 
VDR gene polymorphisms, and cathelicidin levels. 
Another study by Leis et al. [16], in a post hoc 
analysis, found that Vitamin D intake <80 IU/kg/
day was not a risk factor for bronchiolitis (odds ratio 
[OR] = 1.7 (95% confidence interval [CI] 0.7–4.0]), 
but a risk factor for pneumonia (OR = 7.9 [95% CI 
1.8–35.5]). The difference in results may be due to the 
difference in methods. Leis et al. [16] only measured 
Vitamin D intake, they did not measure calcidiol levels. 
The disruption of enzymes involved in the metabolism 
of Vitamin D, such as 25-OHase or 1-OHase enzymes, 
will influence calcidiol or calcitriol production that will 
also lead to cathelicidin production during adequate 
Vitamin D intake. In addition, Leis et al. [16] did not 
investigate the role of VDR gene polymorphisms. The 
difference in the genotype of the Fok1 VDR gene also 
influences the incidence of ALRIs [22].
Subgroup analysis of our study found that 
Vitamin D deficiency has a greater effect size for 
bronchiolitis than pneumonia. This result may be due 
to the cause of bronchiolitis, generally virus, especially 
respiratory syncytial virus (RSV), while pneumonia can 
be caused by a bacteria or virus. Litonjua [38] stated 
that Vitamin D reduces the inflammation that occurs 
after viral (RSV) infection.
VDR gene polymorphisms are also associated 
with ALRIs. VDR gene instructs the body to make a protein 
called VDR that will enable the body to respond to Vitamin 
D [39]. In some ethnicities, VDR is highly polymorphic. 
There are several polymorphisms that have been reported 
for the VDR gene; one of them is Fok1 that is located at 
exon 2 [40]. Polymorphisms in Fok1 occur due to changes 
in the thymine/cytosine (T/C) sequence [41] with basic 
alteration on codon ATG to ACG at the first potential start 
site [42]. Based on gene sequencing at exons 2, we found 
only Fok1 VDR gene polymorphisms.
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The Fok1 VDR gene consists of three 
genotypes, that is, ff, Ff, and FF. The ff genotype is 
less active in transcription the cathelicidin gene and will 
lead to low cathelicidin levels, and therefore a higher 
risk to suffer from ALRIs [22]. The short 424 amino acid 
(aa) VDR protein variant (the “C” allele or “F” allele) has 
greater activity (1.7 times) than long 427 a variant (the 
“T” allele or “f” allele) in its transactivation capacity as 
a transcription factor [41]. This study found that the ff 
genotype-Fok1 VDR gene was not a risk factor of ALRIs 
compared to the FF genotype. These results support 
a previous study that found no difference between 
VDR gene polymorphisms in children with recurrent 
tonsillopharyngitis compared to healthy children [26]. 
Different results were obtained by Roth et al. [21] who 
conducted a case–control study in children aged 1–24 
months. They observed that the ff genotype-Fok1 
VDR gene was a risk factor of ALRIs (predominant 
bronchiolitis) compared to the FF genotype (OR = 7.38 
[95% CI = 1.17–46.55], p = 0.033). The difference in 
results occurs due to the control subjects. The control 
subject of our study was healthy subjects during the 
study period (that perhaps previously had ALRIs), while 
Roth et al. [21] used 1–24 months age subjects that 
were hospitalized for surgical reasons, without a history 
of hospitalization due to ALRIs. Another possible cause 
of the different results is the differences in ethnicity.
Our study also found that low levels of cathelicidin 
were 4 times more likely to cause ALRIs. Similar results 
are shown in other studies. Albanna et al. [25] performed 
a case–control study in Egyptian children and found that 
children with cathelicidin levels <20 ng/mL were risk factor 
for pneumonia compared to children with cathelicidin 
levels >20 ng/mL (OR = 10.33 [95% CI = 3.31–33.62], 
p < 0.001). A study on adults reported higher rates of death 
from infectious disease in subjects who have low levels of 
circulating cathelicidin (OR = 3.7 [95% CI = 1.2–11.2]) [24].
Cathelicidin has broad-spectrum antimicrobial 
activity against microorganisms [43], [44]. Transcription 
of cathelicidin antimicrobial peptide (CAMP) is 
increased during bacteria, viruses, fungi, or protozoa 
infections [45]. The antigen of these agents will activate 
toll-like receptor-2; this receptor then triggers response 
mediated by Vitamin D in the form of the interaction 
between calcitriol and VDR. This interaction will activate 
CAMP genes to express cathelicidin. This evidence 
makes Vitamin D as an important factor in the regulation 
of cathelicidin and can explain the antimicrobial role of 
Vitamin D [33], [46].
In contrast to our study, Leow et al. [27] 
performed a cohort study in adults with pneumonia that 
was selected by convenient sampling and found that 
cathelicidin and β-defensin-2 cannot predict mortality. 
Differences in results may be due to differences in age 
(children are not representative of adults), outcomes, 
and sample selection.
On subgroup analysis, we found that low 
levels of cathelicidin have a greater effect size 
in for bronchiolitis than pneumonia. This result 
was consistent with the results of the subgroup 
analysis for Vitamin D levels. Some studies have 
shown a positive correlation between the levels of 
Vitamin D and cathelicidin [25], [45], [47]. Greater 
effect size in bronchiolitis than pneumonia is possibly 
due to the proportion of the virus causing bronchiolitis 
that is greater than the proportion of the virus causing 
pneumonia. Miller et al. [48] reported that the causes 
of bronchiolitis are RSV (76%), human rhinovirus 
(18%), influenza virus (10%), human metapneumovirus 
(3%), coronavirus (2%), and parainfluenza virus 
(PIV) 1%, while only 30% of pneumonia are caused 
by viruses [49], of which 20% due to RSV, 3% by the 
influenza virus, and 7% due to PIV [10]. RNA virus 
will increase active Vitamin D on epithelial cells of the 
respiratory system and expression of cathelicidin (this 
does not happen on bacterial antigen wall component). 
Vitamin D will upregulate cathelicidin expression in the 
epithelial cells of the respiratory system and plays an 
important role in host defense. Vitamin D also activates 
the secretion of β-defensin-2 from neutrophils. Beta-
defensin-2 has activity against RSV, influenza virus, 
PIV, and adenovirus [50].
As far as we know, this is the first study that 
simultaneously identifies the association between 
Vitamin D deficiency, Fok1 VDR gene polymorphism, 
and low levels of cathelicidin with ALRIs in children 
under five. This study also found Vitamin D deficiency 
and low levels of cathelicidin as a risk factor for ALRIs 
with a different cut off point to the previous studies 
and also got a greater effect size for bronchiolitis than 
pneumonia.
This study had several limitations, such as 
control patients not being assessed for history of ALRI, 
infection cause (viral or bacterial) not being investigated, 
and calcium, parathyroid hormone, and 1-OHase levels 
not being measured.
Conclusion
Finally, we conclude that Vitamin D deficiency 
and low levels of cathelicidin are risk factors, but 
ff-genotype-VDR gene polymorphisms are not a risk 
factor of ALRIs. Subjects with Vitamin D deficiency or 
low levels of cathelicidin have a greater risk of suffering 
from bronchiolitis than pneumonia. Fok1 VDR gene is 
the only picture of exon 2-VDR gene polymorphisms. 
To prevent Vitamin D deficiency, we suggest that sun 
exposure during the daytime is essential (4–10 min 
for white ethnics, 60–80 min for black ethnics, and 
among for brown skin) [29], children under five must 
have a diet that contains 400 IU/day of Vitamin D [31] 
and occasionally measure Vitamin D levels in children. 
Further studies are needed to examine calcium, 
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parathyroid hormone, and 1-OHase enzyme and the 
control selection using children that have never suffered 
from ALRI.
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